相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mesalamine Protects Against Colorectal Cancer in Inflammatory Bowel Disease
Jeffrey Tang et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Mesalamine Inhibits Epithelial β-Catenin Activation in Chronic Ulcerative Colitis
Jeffrey B. Brown et al.
GASTROENTEROLOGY (2010)
Mesalazine inhibits the beta-catenin signalling pathway acting through the upregulation of mu-protocadherin gene in colo-rectal cancer cells
S. Parenti et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Inhibition of cell proliferation and invasion in a human colon cancer cell line by 5-aminosalicylic acid
Y. -H. Kim et al.
DIGESTIVE AND LIVER DISEASE (2009)
Crypt stem cells as the cells-of-origin of intestinal cancer
Nick Barker et al.
NATURE (2009)
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Maximilian Diehn et al.
NATURE (2009)
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid
Carmine Stolfi et al.
BIOCHEMICAL PHARMACOLOGY (2008)
PPARγ is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells
Markus Schwab et al.
CARCINOGENESIS (2008)
Epithelial: Lamina propria lymphocyte interactions promote epithelial cell differentiation
Stephanie Dahan et al.
GASTROENTEROLOGY (2008)
Rosiglitazone for active ulcerative colitis: A randomized placebo-controlled trial
James D. Lewis et al.
GASTROENTEROLOGY (2008)
Characterization, of epithelial IL-8 response to inflammatory bowel disease mucosal E-coli and its inhibition by mesalamine
Sreedhar Subramanian et al.
INFLAMMATORY BOWEL DISEASES (2008)
Peroxisome proliferator-activated receptor γ (PPARγ) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the β-catenin/T cell factor (TCF) pathway
Toshio Fujisawa et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis
Hong-Liang Liang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Identification of stem cells in small intestine and colon by marker gene Lgr5
Nick Barker et al.
NATURE (2007)
Modulation of PPAR activity via phosphorylation
Katherine A. Burns et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
MAPK kinases as nucleo-cytoplasmic shuttles for PPARγ
Elke Burgermeister et al.
CELL CYCLE (2007)
5-ASA affects cell cycle progression in colorectal cells by reversibly activating a replication checkpoint
M. Gloria Luciani et al.
GASTROENTEROLOGY (2007)
Drug insight: aminosalicylates for the treatment of IBD
Ole H. Nielsen et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2007)
Wnt signaling and gastrointestinal tumorigenesis in mouse models
M. M. Taketo
ONCOGENE (2006)
Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis
David T. Rubin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Functional interaction between peroxisome proliferator-activated receptor γ and β-catenin
Jiajian Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
PPAR gamma as a new therapeutic in inflammatory bowel diseases
L. Dubuquoy et al.
GUT (2006)
Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: A systematic review and metaanalysis of observational studies
FS Velayos et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-γ
C Rousseaux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Newborn neurons acquire high levels of reactive oxygen species and increased mitochondrial proteins upon differentiation from progenitors
M Tsatmali et al.
BRAIN RESEARCH (2005)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells
H Sheng et al.
GUT (2003)
Peroxisome proliferator-activated receptor γ-mediated differentiation -: A mutation in colon cancer cells reveals divergent and cell type-specific mechanisms
RA Gupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis
WJ Sandborn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter
GD Girnun et al.
MOLECULAR ENDOCRINOLOGY (2002)
The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells
M van de Wetering et al.
CELL (2002)
Reversible inactivation of the tumor suppressor PTEN by H2O2
SR Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
T-cell factors: turn-ons and turn-offs
A Hurlstone et al.
EMBO JOURNAL (2002)
Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex
F Vazquez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Target genes of peroxisome proliferator-activated receptor γ in colorectal cancer cells
RA Gupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Tumor suppressor and anti-inflammatory actions of PPARγ agonists are mediated via upregulation of PTEN
L Patel et al.
CURRENT BIOLOGY (2001)
Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell
J Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
5-aminosalicylic acid and olsalazine inhibit tumor growth in a rodent model of colorectal cancer
WA Brown et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
分享论文
